Eric C. Ko

1.6k total citations
47 papers, 1.2k citations indexed

About

Eric C. Ko is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Organic Chemistry. According to data from OpenAlex, Eric C. Ko has authored 47 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 11 papers in Pulmonary and Respiratory Medicine and 10 papers in Organic Chemistry. Recurrent topics in Eric C. Ko's work include Immunotherapy and Immune Responses (8 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Prostate Cancer Diagnosis and Treatment (5 papers). Eric C. Ko is often cited by papers focused on Immunotherapy and Immune Responses (8 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Prostate Cancer Diagnosis and Treatment (5 papers). Eric C. Ko collaborates with scholars based in United States, China and Canada. Eric C. Ko's co-authors include Silvia C. Formenti, David Raben, Johnny Kao, Soldano Ferrone, Samuel Eisenstein, Shibo Fu, Andrew G. Sikora, Xinhui Wang, Xinhui Wang and Richard G. Stock and has published in prestigious journals such as Journal of the American Chemical Society, The Journal of Immunology and PLoS ONE.

In The Last Decade

Eric C. Ko

47 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eric C. Ko United States 18 530 402 314 308 149 47 1.2k
Mary Brummet United States 22 369 0.7× 365 0.9× 414 1.3× 355 1.2× 452 3.0× 47 1.3k
Paal Brunsvig Norway 18 787 1.5× 380 0.9× 592 1.9× 456 1.5× 70 0.5× 46 1.4k
Takashi Nakano Japan 22 843 1.6× 369 0.9× 466 1.5× 1.1k 3.7× 181 1.2× 47 2.0k
Masakazu Sugaya Japan 21 643 1.2× 449 1.1× 574 1.8× 328 1.1× 135 0.9× 68 1.4k
Ramona F. Swaby United States 22 1.1k 2.0× 217 0.5× 289 0.9× 621 2.0× 122 0.8× 83 1.8k
Helen Merkens Canada 20 387 0.7× 181 0.5× 325 1.0× 391 1.3× 589 4.0× 66 1.5k
James Russell United States 20 396 0.7× 185 0.5× 213 0.7× 623 2.0× 230 1.5× 45 1.4k
Maeva Dufies France 25 388 0.7× 247 0.6× 209 0.7× 734 2.4× 52 0.3× 46 1.5k
Patrick Maier Germany 16 263 0.5× 111 0.3× 140 0.4× 417 1.4× 139 0.9× 31 889
Delphine L. Chen United States 21 244 0.5× 123 0.3× 522 1.7× 432 1.4× 334 2.2× 79 1.3k

Countries citing papers authored by Eric C. Ko

Since Specialization
Citations

This map shows the geographic impact of Eric C. Ko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric C. Ko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric C. Ko more than expected).

Fields of papers citing papers by Eric C. Ko

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric C. Ko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric C. Ko. The network helps show where Eric C. Ko may publish in the future.

Co-authorship network of co-authors of Eric C. Ko

This figure shows the co-authorship network connecting the top 25 collaborators of Eric C. Ko. A scholar is included among the top collaborators of Eric C. Ko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric C. Ko. Eric C. Ko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Shen, James, Kevin W. O’Connor, Janaki Moni, et al.. (2022). Definitive Radiation Therapy for Medically Inoperable Endometrial Carcinoma. Advances in Radiation Oncology. 8(1). 101003–101003. 3 indexed citations
3.
Agrawal, Vishesh, et al.. (2020). Radiotherapy and Immunotherapy Combinations for Lung Cancer. Current Oncology Reports. 23(1). 4–4. 16 indexed citations
4.
Altorki, Nasser K., Alain Borczuk, Ashish Saxena, et al.. (2019). P2.04-92 Neoadjuvant Durvalumab With or Without Sub-Ablative Stereotactic Radiotherapy (SBRT) in Patients with Resectable NSCLC (NCT02904954). Journal of Thoracic Oncology. 14(10). S746–S746. 14 indexed citations
5.
Ko, Eric C. & Silvia C. Formenti. (2019). Radiation therapy to enhance tumor immunotherapy: a novel application for an established modality. International Journal of Radiation Biology. 95(7). 936–939. 57 indexed citations
6.
Ko, Eric C. & Silvia C. Formenti. (2018). Radiotherapy and checkpoint inhibitors: a winning new combination?. Therapeutic Advances in Medical Oncology. 10. 3861383280–3861383280. 84 indexed citations
7.
Ko, Eric C., et al.. (2018). Generating antitumor immunity by targeted radiation therapy: Role of dose and fractionation. Advances in Radiation Oncology. 3(4). 486–493. 46 indexed citations
8.
Valicenti, Richard K., Stephanie L. Pugh, Edouard J. Trabulsi, et al.. (2017). First Report of NRG Oncology/Radiation Therapy Oncology Group 0622: A Phase 2 Trial of Samarium-153 Followed by Salvage Prostatic Fossa Irradiation in High-Risk Clinically Nonmetastatic Prostate Cancer After Radical Prostatectomy. International Journal of Radiation Oncology*Biology*Physics. 100(3). 695–701. 4 indexed citations
9.
Wei, Xiao X., Eric C. Ko, & Charles J. Ryan. (2017). Treatment strategies in low-volume metastatic castration-resistant prostate cancer. Current Opinion in Urology. 27(6). 596–603. 12 indexed citations
10.
Ma, Ge, Neil Gildener‐Leapman, Samuel Eisenstein, et al.. (2015). Myeloid-Derived Suppressor Cells as an Immune Parameter in Patients with Concurrent Sunitinib and Stereotactic Body Radiotherapy. Clinical Cancer Research. 21(18). 4073–4085. 90 indexed citations
11.
DʼSouza, Gypsyamber, Thomas E. Carey, William N. William, et al.. (2013). Epidemiology of Head and Neck Squamous Cell Cancer Among HIV-Infected Patients. JAIDS Journal of Acquired Immune Deficiency Syndromes. 65(5). 603–610. 51 indexed citations
12.
Fu, Shibo, Ying Yang, Yun Yen, et al.. (2012). γ-H2AX Kinetics as a Novel Approach to High Content Screening for Small Molecule Radiosensitizers. PLoS ONE. 7(6). e38465–e38465. 25 indexed citations
13.
Ko, Eric C., Kevin Forsythe, Michael Buckstein, Johnny Kao, & Barry S. Rosenstein. (2011). Radiobiological rationale and clinical implications of hypofractionated radiation therapy. Cancer/Radiothérapie. 15(3). 221–229. 18 indexed citations
14.
Fu, Shibo, Michael Rivera, Eric C. Ko, et al.. (2011). Combined Inhibition of Epidermal Growth Factor Receptor and Cyclooxygenase-2 as a Novel Approach to Enhance Radiotherapy. PubMed. 2(3). 15 indexed citations
15.
Ko, Eric C., Christopher D. Koprowski, Diana Dickson-Witmer, et al.. (2010). Partial vs. whole breast irradiation in a community hospital: A retrospective cohort analysis of 200 patients. Brachytherapy. 9(3). 248–253. 10 indexed citations
16.
Kao, Johnny, et al.. (2010). Targeting immune suppressing myeloid-derived suppressor cells in oncology. Critical Reviews in Oncology/Hematology. 77(1). 12–19. 119 indexed citations
17.
Ko, Eric C., Wei Luo, Liaomin Peng, Xinhui Wang, & Soldano Ferrone. (2007). Mouse Dendritic-Endothelial Cell Hybrids and 4-1BB Costimulation Elicit Antitumor Effects Mediated by Broad Antiangiogenic Immunity. Cancer Research. 67(16). 7875–7884. 16 indexed citations
18.
Peng, Liaomin, Eric C. Ko, Wei Luo, et al.. (2006). CD4-Dependent Potentiation of a High Molecular Weight-Melanoma-Associated Antigen-Specific CTL Response Elicited in HLA-A2/Kb Transgenic Mice. The Journal of Immunology. 176(4). 2307–2315. 8 indexed citations
19.
Wang, Xinhui, Michael Campoli, Eric C. Ko, Wei Luo, & Soldano Ferrone. (2004). Enhancement of scFv fragment reactivity with target antigens in binding assays following mixing with anti-tag monoclonal antibodies. Journal of Immunological Methods. 294(1-2). 23–35. 20 indexed citations
20.
Larson, Jennifer L., Eric C. Ko, & Andrew D. Miranker. (2000). Direct measurement of islet amyloid polypeptide fibrillogenesis by mass spectrometry. Protein Science. 9(2). 427–431. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mary Brummet Breakdown of academic impact, for papers by Paal Brunsvig Breakdown of academic impact, for papers by Takashi Nakano Breakdown of academic impact, for papers by Masakazu Sugaya Breakdown of academic impact, for papers by Ramona F. Swaby Breakdown of academic impact, for papers by Helen Merkens Breakdown of academic impact, for papers by James Russell Breakdown of academic impact, for papers by Maeva Dufies Breakdown of academic impact, for papers by Patrick Maier Breakdown of academic impact, for papers by Delphine L. Chen
Rankless by CCL
2026